stock takes

Here are 7 key moments from Jim Cramer’s interview of Donald Trump from the NYSE
President-elect Donald Trump told CNBC’s Jim Cramer on Thursday the stock market is “going to see a lot of good days ahead.” Jim interviewed Trump on the floor of the New York Stock Exchange moments after the president-elect rang the opening bell. In their wide-ranging discussion, Trump said the performance of the stock market is […]
Read More
Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
New trial data has cemented Club holding Eli Lilly ‘s pole position in the highly competitive obesity drug race. The news Eli Lilly’s obesity drug Zepbound bested its main rival Wegovy — made by Denmark’s Novo Nordisk — in the first head-to-head trial comparing the fast-growing weight loss treatments. Patients on Zepound lost an average […]
Read More
How we’re thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
Enthusiasm for Club holding Eli Lilly needs to be tempered — at least for now — as Wall Street grapples with the possibility of a major shakeup to health policy in Washington. The news Republican President-elect Donald Trump on Thursday nominated prominent vaccine skeptic and obesity-drug critic Robert F. Kennedy Jr. to lead the Department […]
Read More
Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction
Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a trial over the safety of its formula for premature babies. The news Abbott Labs’ specialized formula is not responsible for a young baby boy developing a severe intestinal illness known as necrotizing enterocolitis, or NEC, a jury in Missouri […]
Read More
GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
GE Healthcare ‘s quiet outperformance is becoming harder to tune out — and its new drug used in radiology to improve the diagnosis of heart disease can help the Club stock make some more noise. In a note to clients Sunday, Wells Fargo analysts said that GE Healthcare’s diagnostic agent Flyrcado is “possibly the most […]
Read More
3 ways Wall Street’s largest banks are leveraging AI to increase profitability
Big banks are jumping headfirst into the AI race. Over the past year, Wall Street’s largest names — including Goldman Sachs , Bank of America , Morgan Stanley , Wells Fargo to JPMorgan Chase — ramped up their generative artificial intelligence efforts with the aim of boosting profits. Some are striking deals and partnerships to […]
Read More
Cramer names the No. 1 underappreciated megacap to buy in the recent tech stock sell-off
Microsoft’s generative artificial intelligence prospects are impressive. But the stock has more to offer investors than just the new tech. Jim Cramer said Microsoft shares could bottom Wednesday — and out of all the megacap tech stocks, this Club name is the one to buy. Microsoft closed at a record high of $467 on July […]
Read More
Jim Cramer says a double developer stock upgrade signals city real estate back
Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Lowe’s : The home improvement retailer beat on earnings but missed on revenues. Lowe’s also cut its full-year outlook. Shares were higher earlier but turned modestly negative. “The stock is hanging because of the Federal Reserve. No one […]
Read More
Catalyst calendar: Here’s a look at major events that could propel these 7 stocks higher
AI tech stocks have been on the rage on Wall Street. But here are some events that could lift other Club names higher in the weeks and months ahead. Source
Read More
Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks
Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Oracle : The tech giant had a mixed quarter. But it announced new artificial intelligence partnerships with Alphabet ‘s Google and Microsoft -backed OpenAI. Oracle also reported strong RPO, short for remaining performance obligation. RPO is what contracted […]
Read More